Neoadjuvant therapy for breast cancer has no benefits on overall survival or on the mastectomy rate in routine clinical practice. A population-based study with a median follow-up of 11years using propensity score matching
Titel:
Neoadjuvant therapy for breast cancer has no benefits on overall survival or on the mastectomy rate in routine clinical practice. A population-based study with a median follow-up of 11years using propensity score matching
Auteur:
Le Ray, I. Dabakuyo, S. Crehange, G. Bardou, M. Arnould, L. Fraisse, J. Fumoleau, P. Coudert, B. Causeret, S. Arveux, P. Maingon, P. Bonnetain, F.